INAB (STOCKS)
IN8bio, Inc. Common Stock
$2.050000
+0.140000 (+7.33%)
Prev close: $1.910000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- William T. Ho
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $19.09M
- Employees
- 18
- P/E (TTM)
- -0.30
- P/B (TTM)
- 0.66
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $394.00K |
| Benefits Costs and Expenses | $26.61M |
| Costs And Expenses | $21.05M |
| Operating Expenses | $21.05M |
| Research and Development | $11.16M |
| Other Operating Expenses | $9.90M |
| Operating Income/Loss | -$20.66M |
| Income/Loss From Continuing Operations After Tax | -$20.66M |
| Income/Loss From Continuing Operations Before Tax | -$26.21M |
| Net Income/Loss | -$20.66M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$20.66M |
| Net Income/Loss Available To Common Stockholders, Basic | -$20.66M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $11.27 |
| Diluted Earnings Per Share | $11.27 |
| Basic Average Shares | 55,497,328 |
| Diluted Average Shares | 55,497,328 |
| Assets | $16.77M |
| Current Assets | $11.77M |
| Noncurrent Assets | $5.00M |
| Fixed Assets | $2.10M |
| Other Non-current Assets | $2.90M |
| Liabilities | $3.58M |
| Current Liabilities | $1.70M |
| Accounts Payable | $204.00K |
| Other Current Liabilities | $1.50M |
| Noncurrent Liabilities | $1.88M |
| Equity | $13.19M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $13.19M |
| Liabilities And Equity | $16.77M |
| Net Cash Flow From Operating Activities | -$14.60M |
| Net Cash Flow From Operating Activities, Continuing | -$14.60M |
| Net Cash Flow From Investing Activities | $391.00K |
| Net Cash Flow From Investing Activities, Continuing | $391.00K |
| Net Cash Flow From Financing Activities | $21.34M |
| Net Cash Flow From Financing Activities, Continuing | $21.34M |
| Net Cash Flow | $7.13M |
| Net Cash Flow, Continuing | $7.13M |
| Comprehensive Income/Loss | -$20.66M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$20.66M |
| Other Comprehensive Income/Loss | $0.00 |